Operating performance improved significantly during the quarter. EBITDA rose to Rs 307.4 crore from Rs 147.3 crore in the same period last year, while EBITDA margin increased from 24.3% to 34.4%, due to stronger operating leverage and a favorable business mix.In terms of revenue breakdown, HPP (high-performance products), which includes refrigerants and inorganic fluorides, reported a 35% increase in revenue to Rs 412 crore in Q3FY26. The specialty chemicals business posted a 60% increase to Rs 354 crore, while the CDMO business rose 61% in terms of turnover to Rs 127 crore, the company’s regulatory filings showed.
Also read | Quant MF reduces exposure to gold and silver near peak levels in multi-asset funds
The HPP segment reported revenue growth during the period, supported by higher realizations and higher volumes. The AHF capex was commissioned in Q4FY26 and shipments have already started. It also noted that the price environment for HFC remains constructive.
The specialty chemicals company continues to maintain a strong product pipeline, with scale-up of existing molecules underway and the launch of new molecules planned. Debottlenecking of MPP capacity at the Dahej facility is progressing as planned and is expected to be commissioned in Q3 27. The segment delivered its highest quarterly performance ever and the outlook remains positive, supported by strong order visibility for the fourth quarter and beyond. The CDMO business maintained its momentum with robust order visibility. The company highlighted progress in its strategy, focusing on a balanced portfolio with a mix of early and late or commercial stage molecules. Deliveries for a material order to one EU major have been completed and discussions on future deliveries are ongoing, while another EU major has placed a scale-up order scheduled for deliveries in the fourth quarter.
Navin Fluorine is a specialty fluorochemical manufacturer serving global customers in pharmaceuticals, agricultural chemicals, specialty chemicals and performance materials.
(Disclaimer: Recommendations, suggestions, views and opinions expressed by the experts are their own. These do not represent the views of The Economic Times.)
#Navin #Fluorine #shares #focus #net #profit #rises #crore

